Linezolid som behandling af infektiøs endokarditis

Trine Kiilerich Lauridsen; Magnus Arpi; Niels Eske Bruun

Linezolid som behandling af infektiøs endokarditis

Trine Kiilerich Lauridsen^*, Magnus Arpi, Niels Eske Bruun

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review

Abstract

In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.

Bidragets oversatte titel	Linezolid therapy for infectious encocarditis
Originalsprog	Dansk
Tidsskrift	Ugeskrift for laeger
Vol/bind	172
Udgave nummer	16
Status	Udgivet - 1 apr. 2010

Andre filer og links

http://www.scopus.com/inward/record.url?scp=77952294467&partnerID=8YFLogxK

Citationsformater

@article{f8dc1db22e84410698714cb409d424d8,

title = "Linezolid som behandling af infekti{\o}s endokarditis",

abstract = "In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.",

author = "Lauridsen, {Trine Kiilerich} and Magnus Arpi and Bruun, {Niels Eske}",

year = "2010",

month = apr,

day = "1",

language = "Dansk",

volume = "172",

journal = "Ugeskrift for laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "16",

}

TY - JOUR

T1 - Linezolid som behandling af infektiøs endokarditis

AU - Lauridsen, Trine Kiilerich

AU - Arpi, Magnus

AU - Bruun, Niels Eske

PY - 2010/4/1

Y1 - 2010/4/1

N2 - In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.

AB - In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.

UR - http://www.scopus.com/inward/record.url?scp=77952294467&partnerID=8YFLogxK

M3 - Artikel

C2 - 20423667

AN - SCOPUS:77952294467

SN - 0041-5782

VL - 172

JO - Ugeskrift for laeger

JF - Ugeskrift for laeger

IS - 16

ER -

Linezolid som behandling af infektiøs endokarditis

Abstract

Andre filer og links

Fingeraftryk

Citationsformater